Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.
about
Cardiovascular pharmacogenomics: current status and future directionsPersonalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomicsProgress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicitySelf-reported race/ethnicity in the age of genomic research: its potential impact on understanding health disparitiesWhat does genomic medicine mean for diverse populations?STRATEGIES FOR EQUITABLE PHARMACOGENOMIC-GUIDED WARFARIN DOSING AMONG EUROPEAN AND AFRICAN AMERICAN INDIVIDUALS IN A CLINICAL POPULATIONEthnicity-specific pharmacogenetics: the case of warfarin in African AmericansGenetic epidemiology: the potential benefits and challenges of using genetic information to improve human health.Shared and independent colorectal cancer risk alleles in TGFβ-related genes in African and European AmericansDesign and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.Hybrid curation of gene-mutation relations combining automated extraction and crowdsourcingGenetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.Pharmacogenetics in Jewish populations.Spatial localization of recent ancestors for admixed individuals.Warfarin pharmacogenetics.Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.Novel single nucleotide polymorphism in CYP2C9 is associated with changes in warfarin clearance and CYP2C9 expression levels in African Americans.Use of oral anticoagulants in African-American and Caucasian patients with atrial fibrillation: is there a treatment disparity?Pharmacogenomics in cardiology--genetics and drug response: 10 years of progress.Warfarin pharmacogenomics and African ancestry.Race influences warfarin dose changes associated with genetic factors.Genome-wide association study of warfarin maintenance dose in a Brazilian sampleParsing interindividual drug variability: an emerging role for systems pharmacology.Integrating electronic health record genotype and phenotype datasets to transform patient careImpact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European-Americans and Egyptians.Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users.Novel genetic predictors of venous thromboembolism risk in African Americans.Effect of Left Ventricular Systolic Dysfunction on Response to WarfarinPopulation-specific single-nucleotide polymorphism confers increased risk of venous thromboembolism in African Americans.Atrial Fibrillation and Race - A Contemporary Review.Comparison of study designs used to detect and characterize pharmacogenomic interactions in nonexperimental studies: a simulation study.Cardiovascular pharmacogenomics: expectations and practical benefits.Priority pharmacogenetics for the African continent: focus on CYP450.Warfarin pharmacogenetics: to genotype or not to genotype, that is the question.Pharmacogenetics of coumarin anticoagulants in Brazilians.Genotype-guided coumarin dosing: where are we now and where do we need to go next?Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure Response.Pharmacogenetic Markers of Drug Efficacy and Toxicity.Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology.
P2860
Q26801183-74478895-CC96-46B6-9B20-945AE001B608Q26822796-36EEDC0E-2551-40E8-BEB7-98FACD41BE1FQ28083100-284255F2-916E-4D65-8DA4-FE8E9F3683B6Q28651487-B1370499-3B05-463A-94C9-92D5A611F3FEQ28659678-83397070-0273-4018-A5F4-736C0653134CQ33557032-1947885E-77D1-4DCF-BE66-DDB590EE0C8AQ33591111-DEDB7509-E153-4790-BF9E-9D0C6969D63AQ33698750-3B91687A-B4F4-4A7E-865E-D19A4EB67207Q34096798-4EFD4C0E-A331-4A7D-9F3D-1EE570240431Q34216807-DC454076-A8EF-4AA9-8949-0DC4BBD3505DQ34221562-00C85855-74FE-4E41-8A65-45603341C62CQ34284362-B0321C2A-6426-480C-AECA-FD258BAF538CQ34458720-83453C34-A2F4-4B5D-8E29-B7A9B46D550DQ34714023-FCA368F8-19FE-4655-A92B-70411051E23FQ34785072-C77301B0-DD40-45C8-B6FF-C6DE9052CD38Q34791041-6DFBCDAE-A436-4F62-BC90-8DBB052F69B7Q35565624-DECCCC23-E371-46EB-9839-6FC9ACBAF377Q35612111-01FBCA16-D8B8-44AE-B4A4-B046054BD09BQ35654365-E5F0F1FE-47AA-4075-98A6-80285AD3C8A0Q35769279-468BB799-224B-46CB-973E-E8DE5E52E064Q35884246-41036292-8A2F-42F4-B815-D57E5C6CA2CBQ35884265-19BD8997-58F9-456E-A55C-3283307BA933Q36068687-5A10AFF6-355C-4E99-AA01-82E91F0F9491Q36417380-211B5D1B-0A0F-41E0-864E-59BB5B4C6FADQ36599112-F663EEE2-34D6-47CD-B250-6B330770B195Q36599219-C2EC2EF2-6B5B-4CB2-BD01-337730EDEB04Q36717256-6E9D25B2-3B9F-4859-859B-19156C4ABD4BQ36800467-848A5A12-4B4C-4E1F-B792-4FA863EC1507Q37128536-C24C2A93-E8AC-4378-B119-23E67B5D5248Q37257102-8DAD2AB4-27C7-4D41-AECD-B9F9A1C749D9Q37274009-94697746-E6B1-482A-9E55-449436730BA0Q37624739-1012FDCB-5064-479C-9999-02C8BA56CC4AQ38169969-05909B0A-4DB3-4316-9315-0663B73E3D11Q38188600-3D258A51-5C32-42D2-8501-3603A38C1425Q38221329-6D647FF9-20AF-4153-A746-5E6604475DF7Q38262829-7B9A4A07-9706-41A7-BC8C-879E343B8BF6Q38321269-8CF9C0EF-169A-41F8-9862-1D0B2970FE07Q38381894-7C2DDAD3-2F07-4022-9CD6-01F57D193FB3Q38419534-D48BB950-E7D3-43E7-BD37-E5C18AAE3655Q38655838-3C654015-07B0-47F7-86A1-EBD6547D2A68
P2860
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic variants associated wi ...... genome-wide association study.
@en
Genetic variants associated wi ...... genome-wide association study.
@nl
type
label
Genetic variants associated wi ...... genome-wide association study.
@en
Genetic variants associated wi ...... genome-wide association study.
@nl
prefLabel
Genetic variants associated wi ...... genome-wide association study.
@en
Genetic variants associated wi ...... genome-wide association study.
@nl
P2093
P2860
P50
P1433
P1476
Genetic variants associated wi ...... genome-wide association study.
@en
P2093
Alan H B Wu
Anna Pluzhnikov
Anuar Konkashbaev
Benjamin M Burkley
Dan M Roden
Edith A Nutescu
Harumi Takahashi
Hersh Sagreiya
James K Burmester
Jelai Wang
P2860
P304
P356
10.1016/S0140-6736(13)60681-9
P407
P50
P577
2013-06-05T00:00:00Z